GPX4 and neoplasm: Therapeutically, targeting phosphatidylcholine synthesis and remodeling combined with ferroptosis inducers or glutathione peroxidase 4 inhibitors could sensitize tumors to oxidative cell death while reprogramming stromal elements toward anti-tumor activity.